Walgreens Picks Former Rite Aid CEO to Lead U.S. Business
(Bloomberg) -- Former Rite Aid Corp. Chief Executive Officer John Standley will run Walgreens Boots Alliance's U.S. business, the drugstore company announced Monday.
Standley will replace Richard Ashworth, who left earlier this year to take a job as CEO of Tivity Health Inc. Co-Chief Operating Officer Alex Gourlay has been overseeing the U.S. business, which includes roughly 9,300 drugstores, during the search.
Walgreens is trying to revitalize its business amid broader shifts in the U.S. retail and health-care businesses. CVS Health Corp., its fiercest rival, purchased a health insurer, while Walgreens has inked a slew of smaller partnerships.
“I'm looking forward to accelerating execution of the strategic vision for the future of Walgreens,” Standley said in a statement.
Walgreens shares were down 1% at 9:58 a.m. New York time. They had lost about 34% this year as of Friday's close.
Standley led Rite Aid for nine years, through two failed deals that left the company loaded with debt and much smaller than its rivals. Walgreens CEO Stefano Pessina praised Standley's experience in the statement, saying it will allow him to “hit the ground running.”
Pessina earlier this summer announced that he will step down and move into the executive chairman role. The company is looking for his replacement.
©2020 Bloomberg L.P.
-
We May Need Another Tukaram Mundhe To Fight Air Pollution | The Reason Why
Developers may install basic measures such as sprinklers and green nets, resume work, and continue violating rules when this equipment stops working.
-
Extracting Value From Battery Scrap Could Be Challenging For India | The Reason Why
A discarded lithium-ion battery still contains valuable materials such as lithium, nickel and cobalt. These can be recovered and reused. When such batteries are crushed and shredded, they produce a dark powder called black mass.
-
One El Nino, India Can Handle. Two Could Break The Granary
India's grain stocks can absorb one bad year, but a second El Nino could drain the buffer in two to three years, economists say.
-
India's Troika Of Good Luck | Joining The Dots
As Jensen Huang's exit drags Nvidia down, a cooling AI trade and resilient earnings have revived investor interest in India. A likely RBI rate hike looms.
-
Talking Points This Week: Leadership Shock At Nvidia, Earnings Strength, And The Fog Over Hormuz
The Anthropic IPO pricing and first trading day, Nvidia's upcoming earnings, and any fresh signals from Iran will set the tone for the following week.
-
Signature Play: The Classic Cocktail Is Dead. Or Is It?
Classic cocktails are disappearing from India's cocktail menus. But they're still being ordered, taught to bartenders and borrowed from. So, who's really having the last drink?
-
A New Samvat Wishlist: Inclusive Prosperity And Human Development
India has strengthened its economic foundations through infrastructure, digital access and enterprise. Its next growth chapter must deepen productivity, create better livelihoods and widen participation in prosperity.
-
Love, Sex Aur Dhokha: The Audacious Plot To Spy On Jensen Huang
A Taipei dinner, a Singapore chip buyer and a suspected Chinese asset: inside the alleged spy operation that got close to NVIDIA's Jensen Huang.
-
Ten Things I Learnt This Samvat
Patience can be a trap. Cheap stocks can stay cheap. Leverage can wipe you out. What did Samvat 2082 teach us? Niraj Shah writes on 10 lessons from the year gone by.
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.